Login / Signup

Randomized trial of intravenous immunoglobulin maintenance treatment regimens in chronic inflammatory demyelinating polyradiculoneuropathy.

Krista KuitwaardE BrusseB C JacobsA F J E VranckenF EftimovN C NotermansA J van der KooiW-J R FokkinkD NieboerH F LingsmaI S J MerkiesP A van Doorn
Published in: European journal of neurology (2020)
More frequent lower dosing does not further improve the efficacy of IVIg in stable IVIg-dependent CIDP and does not result in fewer side effects.
Keyphrases
  • oxidative stress
  • high dose
  • combination therapy
  • drug induced